Turner NC, Balmana J, Poncet C, Goulioti T, et al. Niraparib for advanced breast cancer with germline BRCA1 and BRCA2 mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO study. Clin Cancer Res 2021 Jul 22. pii: 1078-0432.CCR-21-0310.
PMID: 34301749